Diverse Resistant Mechanisms Identified Using Serial Next-Generation Sequencing in a Patient With ALK-Rearranged Metastatic Lung Adenocarcinoma: A Case Report
10.1016/j.jtocrr.2023.100512
Saved in:
Main Authors: | Saw, Stephanie Pei Li, Lim, Darren Wan-Teck |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Language: | English |
Published: |
ELSEVIER
2024
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/248890 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement
by: Kim, H.R., et al.
Published: (2014) -
ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy
by: Pimpin Incharoen, et al.
Published: (2017) -
Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer
by: Tan, Chye Ling, et al.
Published: (2022) -
Case report: olaparib use in metastatic lung adenocarcinoma with BRCA2 pathogenic variant
by: Soon, Jonathan Jian Hao, et al.
Published: (2023) -
Characterization of MET-N375S as an Activating Mutation in Squamous Cell Carcinoma of the Lung
by: Kong, Li Ren, et al.
Published: (2024)